A multi-center, open-label, non-comparative study investigating the efficacy and tolerability of Angeliq [estradiol/drospirenone] in postmenopausal Thai women with vasomotor symptoms over three 28-day treatment cycles

Trial Profile

A multi-center, open-label, non-comparative study investigating the efficacy and tolerability of Angeliq [estradiol/drospirenone] in postmenopausal Thai women with vasomotor symptoms over three 28-day treatment cycles

Completed
Phase of Trial: Phase IV

Latest Information Update: 16 Oct 2015

At a glance

  • Drugs Estradiol/drospirenone (Primary)
  • Indications Hot flashes; Menopause
  • Focus Therapeutic Use
  • Most Recent Events

    • 16 Oct 2015 New source identified and integrated (ClinicalTrials.gov; NCT00185328).
    • 16 Dec 2008 Status changed from active, no longer recruiting to completed.
    • 02 Nov 2006 Status change
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top